The LLS Ground-Breaking Precision Medicine Approach Master Trial  BEAT AML Releases Third Year Test Results

  A recent posting by the Leukemia and Lymphoma Society references the Beat AML Master Trial. The trial evaluates targeted therapies to treat acute myeloid leukemia (AML) and was launched…

Continue Reading The LLS Ground-Breaking Precision Medicine Approach Master Trial  BEAT AML Releases Third Year Test Results
Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?
qimono / Pixabay

Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

According to a story from globenewswire.com, the biopharmaceutical company Innovation Pharmaceuticals recently released a report in which recent studies and pre-clinical research has suggested that the company's experimental drug Kevetrin…

Continue Reading Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

Sisters with Multiple Sclerosis Share Their Scary Stevens-Johnson Syndrome Story In an Effort to Spread Awareness

An Unexpected Emergency Kristin Hardy and her sister Margaret are no strangers to rare disease. Kristin has primary progressive multiple sclerosis (MS) and Margaret has relapsing-remitting multiple sclerosis. Margaret also…

Continue Reading Sisters with Multiple Sclerosis Share Their Scary Stevens-Johnson Syndrome Story In an Effort to Spread Awareness
Baby’s Death in Spinal Muscular Atrophy Gene Therapy Trial Could be Linked to Treatment, Company Says
geralt / Pixabay

Baby’s Death in Spinal Muscular Atrophy Gene Therapy Trial Could be Linked to Treatment, Company Says

According to a story from BNN Bloomberg, Novartis AG, a drug company that is nearing the completion of the development of a potentially groundbreaking new gene therapy for spinal muscular…

Continue Reading Baby’s Death in Spinal Muscular Atrophy Gene Therapy Trial Could be Linked to Treatment, Company Says
Over 50% of Ankylosing Spondylitis Patients Relapse After Halting Infliximab, Study Claims
mohamed_hassan / Pixabay

Over 50% of Ankylosing Spondylitis Patients Relapse After Halting Infliximab, Study Claims

According to a story from Healio, a recent study has found that 58 percent of patients with the inflammatory disease ankylosing spondylitis will experience relapse within one year after stopping…

Continue Reading Over 50% of Ankylosing Spondylitis Patients Relapse After Halting Infliximab, Study Claims

87 Businesses Across Two Countries Displayed a Purple Light for Sarcoidosis Awareness Last Month

Sarcoidosis Sarcoidosis is a rare inflammatory condition that causes granulomas to buildup within the organs. These can cause permanent organ damage. While the condition can affect various organs, and presents…

Continue Reading 87 Businesses Across Two Countries Displayed a Purple Light for Sarcoidosis Awareness Last Month